Clinical manifestations associated with novel mutations in the coiled-coil domain of STAT1

Boisson-Dupuis S., Kong X.F., Okada S., Cypowyj S., Puel A., Abel L., and Casanova J.L. Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes Curr. Opin. Immunol. 2012 24 4 364 -378

Chen X., Vinkemeier U., Zhao Y., Jeruzalmi D., Darnell J.E. Jr, and Kuriyan J. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA Cell. 1998 93 5 827 -839

Dupuis S., Jouanguy E., Al-Hajjar S., Fieschi C., Al-Mohsen I.Z., Al-Jumaah S., Yang K., Chapgier A., Eidenschenk C., Eid P., Al Ghonaium A., Tufenkeji H., Frayha H., Al-Gazlan S., Al-Rayes H., Schreiber R.D., Gresser I., and Casanova J.L. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency Nat. Genet. 2003 33 3 388 -391

Grouhi M., Dalal I., Nisbet-Brown E., and Roifman C.M. Cerebral vasculitis associated with chronic mucocutaneous candidiasis J. Pediatr. 1998 133 4 571 -574

Hsia C.C., Sun T.T., Wang Y.Y., Anderson L.M., Armstrong D., and Good R.A. Enhancement of formation of the esophageal carcinogen benzylmethylnitrosamine from its precursors by Candida albicans Proc. Natl. Acad. Sci. USA. 1981 78 3 1878 -1881

Krogh P. The role of yeasts in oral cancer by means of endogenous nitrosation Acta. Odontol. Scand. 1990 48 1 85 -88

Levy D.E. and Darnell J.E. Jr Stats: transcriptional control and biological impact Nat. Rev. Mol. Cell. Biol. 2002 3 9 651 -662

Liu L., Okada S., Kong X.F., Kreins A.Y., Cypowyj S., Abhyankar A., Toubiana J., Itan Y., Audry M., Nitschke P., Masson C., Toth B., Flatot J., Migaud M., Chrabieh M., Kochetkov Y., Zhao T., Bolze A., Borghesi A., Toulon A., Hiller J., Eyerich S., Eyerich K., Gulácsy V., Chernyshova L., Chernyshov V., Bondarenko A., Grimaldo R.M., Blancas-Galicia L., Beas I.M., Roesler J., Magdorf K., Engelhard D., Thumerelle C., Burgel P.R., Hoernes M., Drexel B., Seger R., Kusuma T., Jansson A.F., Sawalle-Belohradsky J., Belohradsky B., Jouanguy E., Bustamante J., Bué M., Karin N., Wildbaum G., Bodemer C., Lortholary O., Fischer A., Blanche S., Al-Muhsen S., Reichenbach J., Kobayashi M., Rosales F.E., Lozano C.T., Kilic S.S., Oleastro M., Etzioni A., Traidl-Hoffmann C., Renner E.D., Abel L., Picard C., Maródi L., Boisson-Dupuis S., Puel A., and Casanova J.L. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis J. Exp. Med. 2011 208 8 1635 -1648

Marodi L., Cypowyj S., Toth B., Chernyshova L., Puel A., and Casanova J.L. Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species J. Allergy. Clin. Immunol. 2012 130 1019 -1027

O'Shea J.J., Holland S.M., and Staudt L.M. JAKs and STATs in immunity, immunodeficiency and cancer N. Engl. J. Med. 2013 368 2 161 -170

Park E.S., Kim H., Suh J.M., Park S.J., Kwon O.Y., Kim Y.K., Ro H.K., Cho B.Y., Chung J., and Shong M. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells Mol. Endocrinol. 2000 14 3 440 -448

Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy J. Clin. Endocrinol. Metab. 2006 91 8 2843 -2850

Rautemaa R., Hietanen J., Niissalo S., Pirinen S., and Perheentupa J. Oral and oesophageal squamous cell carcinoma--a complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I) Oral. Oncol. 2007 43 6 607 -613

Sharfe N., Nahum A., Newell A., Dadi H., Ngan B., Pereira S.L., Herbrick J.A., and Roifman C.M. Fatal combined immunodeficiency associated with heterozygous mutation in STAT1 J. Allergy. Clin. Immunol. 2014 133 3 807 -817

van de Veerdonk F.L., Plantinga T.S., Hoischen A., Smeekens S.P., Joosten L.A., Gilissen C., et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis N. Engl. J. Med. 2011 365 1 54 -61